Melatonin in insomniac patients and effects of sleep medication.
Rodenbeck
A
A
Department of Psychiatry, University of Göttingen, Germany.
Hajak
G
G
Huether
G
G
D000328:Adult; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000494:pharmacology; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000494:pharmacology; D004311:Double-Blind Method; D004316:Doxepin / Q000008:administration & dosage / Q000494:pharmacology*; D005445:Flunitrazepam / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D008297:Male; D008550:Melatonin / Q000097:blood*; D008875:Middle Aged; D011863:Radioimmunoassay; D012016:Reference Values; D007319:Sleep Initiation and Maintenance Disorders / Q000097:blood* / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D006993:Hypnotics and Sedatives; D004316:Doxepin; D005445:Flunitrazepam; D008550:Melatonin